Table 3. Survival rates at different time points grouped by BCLC stage and history of percutaneous treatment.
| SURVIVAL RATES | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BCLC | baseline | 1 year | 2 yrs | 3yrs | 4 yrs | 5 yrs | 6 yrs | 7 yrs | ||||||||
| - | 1 | 0,4% | 1 | 0,4% | 1 | 0,4% | 1 | 0,4% | 1 | 0,4% | 1 | 0,4% | 1 | 0,4% | 1 | 0,4% |
| 0 | 23 | 10,0% | 19 | 8,3% | 17 | 7,4% | 12 | 5,2% | 9 | 3,9% | 7 | 3,0% | 2 | 0,9% | 0 | 0,0% |
| A | 95 | 41,3% | 83 | 36,1% | 60 | 26,1% | 39 | 17,0% | 28 | 12,2% | 18 | 7,8% | 6 | 2,6% | 1 | 0,4% |
| B | 111 | 48,3% | 92 | 40,0% | 57 | 24,8% | 36 | 15,7% | 27 | 11,7% | 17 | 7,4% | 6 | 2,6% | 1 | 0,4% |
| no PT | 141 | 61,3% | 112 | 48,7% | 72 | 31,3% | 44 | 19,1% | 31 | 13,5% | 19 | 8,3% | 7 | 3,0% | 2 | 0,9% |
| PT | 89 | 38,7% | 83 | 36,1% | 63 | 27,4% | 44 | 19,1% | 34 | 14,8% | 24 | 10,4% | 8 | 3,5% | 1 | 0,4% |
| TOTAL | 230 | 100% | 195 | 84,8% | 135 | 58,7% | 88 | 38,3% | 65 | 28,3% | 43 | 18,7% | 15 | 6,5% | 3 | 1,3% |
BCLC = Barcelona Clinic Liver Cancer stage, PT = patients who received a Percutaneous Treatment. The percentages are referred to the whole cohort (n = 230)